We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
Oxford University Innovation's Clinical Outcome team will be attending ISPOR Europe 2024 in Barcelona, Spain from the 17th - 20th November.
Vasculitis is a complex and unpredictable disease, primarily caused by inflammation of the blood vessels.
Oxford University Innovation's Clinical Outcome team will be attending and presenting at the annual ISOQOL 2024 conference in Cologne, Germany from the 13th - 16th October 2024.
The Steroid PRO is now available to licence through the Clinical Outcomes team at Oxford University Innovation.
Discover why Clinical Outcome Assessments (COAs) are vital in clinical trials for measuring patient outcomes and ensuring reliable data for regulatory approval and improved patient care.
Less than two weeks to go! The 8th UK Patient Reported Outcome Measures (PROMs) Research Conference, hosted by our colleagues at the University of Exeter, will be taking place Thursday 20th June 2024.
Post-operative care is a critical phase in the journey towards healing and restored health following a surgical procedure. It's a period where patients require close monitoring and support to ensure a smooth recovery process. While medical interventions are crucial during surgery, the care provided afterward plays an equally significant role in determining the overall outcome.
We are excited to be attending the BIO International Convention 2024, 3rd - 6th June 2024.
Oxford University Innovation's Clinical Outcome team will be attending ISPOR 2024 in Atlanta, Georgia from the 5th - 8th May 2024.
Oxford University Innovation's Clinical Outcome team will be attending BioTrinity 2024 conference in London, UK on the 23-24th April 2024.
